Skip to main content

By becoming a CEVR sponsor, you are supporting our work in healthcare cost-effectiveness and gaining privileged access to valuable data.

By becoming a CEVR sponsor, you are supporting our work in healthcare cost-effectiveness and gaining privileged access to valuable data.

Our researchers at the Center for the Evaluation of Value and Risk in Health (CEVR), including CEVR Director Peter J. Neumann, ScD, frequently contribute their knowledge to a wide range of prestigious, peer-reviewed journals.

Our researchers at the Center for the Evaluation of Value and Risk in Health (CEVR), including CEVR Director Peter J. Neumann, ScD, frequently contribute their knowledge to a wide range of prestigious, peer-reviewed journals.

Read the latest newsletter of the Center for the Evaluation of Value and Risk in Health (CEVR).

Read the latest newsletter of the Center for the Evaluation of Value and Risk in Health (CEVR).

CEVR is a leader on issues pertaining to value, cost-effectiveness and risk tradeoffs in healthcare decisions. We inform national clinical and public health policy issues through our analysis of the benefits, risks and costs of strategies to improve health and healthcare.

CEVR is a leader on issues pertaining to value, cost-effectiveness and risk tradeoffs in healthcare decisions. We inform national clinical and public health policy issues through our analysis of the benefits, risks and costs of strategies to improve health and healthcare.
Since January 2018, the CardioVascular Center has published numerous reports in peer-reviewed journals. These are the highlighted high-impact manuscripts from this quarter.
Our highly trained physicians provide the most advanced care by researching new ways to treat congestive heart failure and other cardiac diseases.
Jump back to top